Probing adenosine receptors using biotinylated purine derivativesJACOBSON, K. A.Methods in enzymology. 1990, Vol 184, pp 668-671, issn 0076-6879, 4 p.Article

Whey protein concentrates as functional ingredients in baked goodsJACOBSON, K. A.Cereal foods world. 1997, Vol 42, Num 3, pp 138-141, issn 0146-6283Article

Visual methods for the nanomolar detection of electrophilic reagentsJACOBSON, K. A; ABRAHAM PATCHORNIK.Journal of biochemical and biophysical methods. 1983, Vol 8, Num 3, pp 213-222, issn 0165-022XArticle

Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A₁ receptor agonistVON LUBITZ, D. K. J. E; LIN, R. C.-S; BISCHOFBERGER, N et al.European journal of pharmacology. 1999, Vol 369, Num 3, pp 313-317, issn 0014-2999Article

Synthesis and biological activity of a new series of N⁶-arylcarbamoyl, 2-(Ar)alkynyl-N⁶-arylcarbamoyl, and N⁶-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A₁ and A3 adenosine receptor agonistsBARALDI, P. G; CACCIARI, B; PARK, K.-S et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 17, pp 3174-3185, issn 0022-2623Article

Adenosine A₃ receptor agonist-induced neurotoxicity in rat cerebellar granule neuronsSEI, Y; VON LUBITZ, D. K. J. E; ABBRACCHIO, M. P et al.Drug development research. 1997, Vol 40, Num 3, pp 267-273, issn 0272-4391Article

Riboflavin : Inhibitory effects on receptors, G-proteins, and adenylate cyclaseDALY, J. W; DAN SHI; PADGETT, W. L et al.Drug development research. 1997, Vol 42, Num 2, pp 98-108, issn 0272-4391Article

Pharmacological characterization of novel A₃ adenosine receptor-selective antagonistsJACOBSON, K. A; PARK, K.-S; JIANG, J.-L et al.Neuropharmacology. 1997, Vol 36, Num 9, pp 1157-1165, issn 0028-3908Conference Paper

Identification of potent P_2Y-purinoceptor agonists that are derivatives of adenosine 5'-monophosphateBOYER, J. L; SIDDIQI, S; FISCHER, B et al.British journal of pharmacology. 1996, Vol 118, Num 8, pp 1959-1964, issn 0007-1188Article

Hemodynamic effects and histamine release elicited by the selective adenosine A₃ receptor agonist 2-Cl-IB-MECA in conscious ratsVAN SCHAICK, E. A; JACOBSON, K. A; KIM, H. O et al.European journal of pharmacology. 1996, Vol 308, Num 3, pp 311-314, issn 0014-2999Article

Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A₁ receptor agonistVON LUBITZ, D. K. J. E; BEENHAKKER, M; LIN, R. C.-S et al.European journal of pharmacology. 1996, Vol 302, Num 1-3, pp 43-48, issn 0014-2999Article

Avian and human homologues of the P2Y₁ receptor : Pharmacological, signaling, and molecular propertiesBAYER, L. L; SCHACHTER, J. B; SROMEK, S. M et al.Drug development research. 1996, Vol 39, Num 3-4, pp 253-261, issn 0272-4391Conference Paper

Differential effects of P₂-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P_2Y-purinoceptorsBOYER, J. L; ZOHN, I. E; JACOBSON, K. A et al.British journal of pharmacology. 1994, Vol 113, Num 2, pp 614-620, issn 0007-1188Article

Structure-activity relationships of N⁶-benzyladenosine-5'-uronamides as A₃-selective adenosine agonistsGALLO-RODRIGUEZ, C; XIAO-DUO JI; STILES, G. L et al.Journal of medicinal chemistry (Print). 1994, Vol 37, Num 5, pp 636-646, issn 0022-2623Article

Covalent binding of a selective agonist irreversibly activates guinea pig coronary artery A₂ adenosine receptorsNIIYA, K; JACOBSON, K. A; SILVIA, S. K et al.Naunyn-Schmiedeberg's archives of pharmacology. 1993, Vol 347, Num 5, pp 521-526, issn 0028-1298Article

Structure-activity relationships of 8-styrylxanthines as A₂-selective adenosine antagonistsJACOBSON, K. A; GALLO-RODRIGUEZ, C; MELMAN, N et al.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 10, pp 1333-1342, issn 0022-2623Article

Identification of potent, selective P_2Y-purinoceptor agonists : structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphateFISCHER, B; BOYER, J. L; HOYLE, C. H. V et al.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 24, pp 3937-3946, issn 0022-2623Article

Adenosine A₁ receptor and ligand molecular modelingDUDLEY, M. W; PEET, N. P; DEMETER, D. A et al.Drug development research. 1993, Vol 28, Num 3, pp 237-243, issn 0272-4391Article

Novel therapeutics acting via purine receptorsJACOBSON, K. A; TRIVEDI, B. K; CHURCHILL, P. C et al.Biochemical pharmacology. 1991, Vol 41, Num 10, pp 1399-1410, issn 0006-2952, 12 p.Article

Demonstration of both A₁ and A₂ adenosine receptors in DDT₁ MF-2 smooth muscle cellsRAMKUMAR, V; BARRINGTON, W. W; JACOBSON, K. A et al.Molecular pharmacology. 1990, Vol 37, Num 2, pp 149-156, issn 0026-895XArticle

Adenosine receptor produgs: towards kidney-selective dialkylxanthinesBARONE, S; CHURCHILL, P. C; JACOBSON, K. A et al.The Journal of pharmacology and experimental therapeutics. 1989, Vol 250, Num 1, pp 79-85, issn 0022-3565Article

¹⁸F-labeled insulin: a prosthetic group methodology for incorporation of a positron emitter into peptides and proteinsSHAI, Y; KIRK, K. L; CHANNING, M. A et al.Biochemistry (Easton). 1989, Vol 28, Num 11, pp 4801-4806, issn 0006-2960, 6 p.Article

Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A₁-adenosine receptorsJACOBSON, K. A; KIRIASIS, L; BARONE, S et al.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 8, pp 1873-1879, issn 0022-2623, 7 p.Article

A prosthetic group for the rapid introduction of fluorine into peptides and functionalized drugsJACOBSON, K. A; FURLANO, D. C; KIRK, K. L et al.Journal of fluorine chemistry. 1988, Vol 39, Num 3, pp 339-347, issn 0022-1139Article

Binary drugs: conjugates of purines and a peptide that bind to both adenosine and substance P receptorsJACOBSON, K. A; LIPKOWSKI, A. W; MOODY, T. W et al.Journal of medicinal chemistry (Print). 1987, Vol 30, Num 8, pp 1529-1532, issn 0022-2623Article